Clinical Trial Update: Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial assesses immune responses after a booster vaccination with Tdap-IPV in children who previously received different pertussis vaccine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Tdap-IPV vaccine (Tetanus toxoid, diphtheria toxoid, acellular pertussis vaccine, inactivated poliovirus vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Pertussis Immunisation, Diphtheria Immunisation | Phase 4 | Status: COMPLETED